Chari S, Mohan V, Snehalatha C, Jayanthi V, Malathi S, Madanagopalan N, Viswanathan M
Department of Digestive Health and Diseases, Government Peripheral Hospital, Anna Nagar, Madras.
Trop Gastroenterol. 1990 Jul-Sep;11(3):144-7.
Faecal chymotrypsin (FCT) levels were estimated in a group of patients with tropical chronic pancreatitis (TCP) and compared with patients with alcoholic chronic pancreatitis (ACP), 'gastrointestinal' controls and 'healthy' subjects. Exocrine pancreatic insufficiency as assessed by low faecal chymotrypsin levels (less than 5.8 mu/g) were present in 85.7 per cent of TPC and 84.6 per cent of ACP patients. Mean FCT levels as well as the distribution of FCT values were similar in TCP and ACP patients and significantly lower than the two control groups (P less than 0.001). There was also no difference with respect to mean FCT levels between subgroups of TCP patients with and without diabetes and those with and without calcification. Faecal chymotrypsin assay is a simple test for diagnosis of chronic pancreatitis in gastroenterological centres in tropical countries.
对一组热带慢性胰腺炎(TCP)患者的粪便糜蛋白酶(FCT)水平进行了评估,并与酒精性慢性胰腺炎(ACP)患者、“胃肠道”对照组和“健康”受试者进行了比较。通过低粪便糜蛋白酶水平(低于5.8μ/g)评估的外分泌性胰腺功能不全在85.7%的TCP患者和84.6%的ACP患者中存在。TCP和ACP患者的平均FCT水平以及FCT值分布相似,且显著低于两个对照组(P<0.001)。有无糖尿病以及有无钙化的TCP患者亚组之间的平均FCT水平也没有差异。粪便糜蛋白酶检测是热带国家胃肠病中心诊断慢性胰腺炎的一种简单检测方法。